» Articles » PMID: 2993779

Polyphosphoinositides and the Shape of Mammalian Erythrocytes

Overview
Journal Lipids
Specialty Biochemistry
Date 1985 Jul 1
PMID 2993779
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between polyphosphoinositide and phosphatidic acid (PA) metabolism and Mg-ATP dependent shape and viscosity changes in erythrocyte ghosts from four mammalian species was examined. Ghosts prepared from rabbit, dog, human and guinea pig erythrocytes were transformed from echinocytes to discocytes within 15 min in the presence of 1 mM Mg-ATP at 25 C. In all species these Mg-ATP shape transformations were associated with a 30-45% decrease in the specific viscosity of the ghost suspensions. Mg-ATP induced a second transformation of discocytic ghosts to cup shape forms without a further decrease in viscosity. A considerable species variation in the rates of Mg-ATP dependent viscosity and shape changes and incorporation of 32P into phosphatidylinositol-4' phosphate (PIP), phosphatidylinositol-4'5'bisphosphate (PIP2) and especially PA from Mg-[gamma 32P]-ATP in ghosts was found. However, the rates of Mg-ATP dependent synthesis of PIP and PIP2 and shape and viscosity changes in each species were of the same magnitude. Ca2+ or neomycin strongly inhibited PIP labeling and Mg-ATP shape and viscosity changes in ghosts of the different species. Ca2+ or neomycin usually increased or had little effect on 32P incorporation into PA and PIP2. The possibility that Mg-ATP-induced changes in erythrocyte membrane shape and deformability are dependent on increases in membrane PIP and PIP2 is discussed.

Citing Articles

Characterization of cytoskeletal protein 4.1R interaction with NHE1 (Na(+)/H(+) exchanger isoform 1).

Nunomura W, Denker S, Barber D, Takakuwa Y, Gascard P Biochem J. 2012; 446(3):427-35.

PMID: 22731252 PMC: 4338608. DOI: 10.1042/BJ20120535.


Correction by pentoxifylline of the abnormal fluorescence polarization of erythrocyte membranes from diabetic patients.

Juhan-Vague I, Roul C, Mourayre Y, Mishal Z, Le Petit J, Vague P Eur J Clin Pharmacol. 1987; 31(6):725-8.

PMID: 3556379 DOI: 10.1007/BF00541304.


Conservative drug therapy and walking exercise in stage IIb peripheral arterial occlusion disease.

Kiesewetter H, Jung F, Blume J, Bulling B, Gerhards M Klin Wochenschr. 1986; 64(20):1061-9.

PMID: 2431197 DOI: 10.1007/BF01757212.


Zinc deficiency in the rat alters the lipid composition of the erythrocyte membrane Triton shell.

Driscoll E, Bettger W Lipids. 1992; 27(12):972-7.

PMID: 1487959 DOI: 10.1007/BF02535574.

References
1.
BARTLETT G . Human red cell glycolytic intermediates. J Biol Chem. 1959; 234(3):449-58. View

2.
Allan D, Michell R . A calcium-activated polyphosphoinositide phosphodiesterase in the plasma membrane of human and rabbit erythrocytes. Biochim Biophys Acta. 1978; 508(2):277-86. DOI: 10.1016/0005-2736(78)90330-9. View

3.
Sheetz M, Febbroriello P, Koppel D . Triphosphoinositide increases glycoprotein lateral mobility in erythrocyte membranes. Nature. 1982; 296(5852):91-3. DOI: 10.1038/296091a0. View

4.
Dawson R, HEMINGTON N, LINDSAY D . The phospholipids of the erythrocyte 'ghosts' of various species. Biochem J. 1960; 77:226-30. PMC: 1204976. DOI: 10.1042/bj0770226. View

5.
Nakao M, Nakao T, YAMAZOE S, Yoshikawa H . Adenosine triphosphate and shape of erythrocytes. J Biochem. 1961; 49:487-92. DOI: 10.1093/oxfordjournals.jbchem.a127333. View